AT356263B - Verfahren zur herstellung eines antigens fuer die verwendung bei der immunologischen kontrolle der fortpflanzung - Google Patents

Verfahren zur herstellung eines antigens fuer die verwendung bei der immunologischen kontrolle der fortpflanzung

Info

Publication number
AT356263B
AT356263B AT377074A AT377074A AT356263B AT 356263 B AT356263 B AT 356263B AT 377074 A AT377074 A AT 377074A AT 377074 A AT377074 A AT 377074A AT 356263 B AT356263 B AT 356263B
Authority
AT
Austria
Prior art keywords
antigent
reproduction
producing
immunological control
immunological
Prior art date
Application number
AT377074A
Other languages
German (de)
English (en)
Other versions
ATA377074A (de
Original Assignee
Univ Ohio State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ohio State filed Critical Univ Ohio State
Publication of ATA377074A publication Critical patent/ATA377074A/de
Application granted granted Critical
Publication of AT356263B publication Critical patent/AT356263B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0006Contraceptive vaccins; Vaccines against sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/5555Muramyl dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6012Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT377074A 1973-05-07 1974-05-07 Verfahren zur herstellung eines antigens fuer die verwendung bei der immunologischen kontrolle der fortpflanzung AT356263B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35789273A 1973-05-07 1973-05-07
US40682173A 1973-10-16 1973-10-16

Publications (2)

Publication Number Publication Date
ATA377074A ATA377074A (de) 1979-09-15
AT356263B true AT356263B (de) 1980-04-25

Family

ID=26999834

Family Applications (1)

Application Number Title Priority Date Filing Date
AT377074A AT356263B (de) 1973-05-07 1974-05-07 Verfahren zur herstellung eines antigens fuer die verwendung bei der immunologischen kontrolle der fortpflanzung

Country Status (17)

Country Link
JP (1) JPS623128B2 (he)
AT (1) AT356263B (he)
AU (1) AU524925B2 (he)
CA (1) CA1057742A (he)
CH (1) CH622426A5 (he)
DD (1) DD113919A5 (he)
DE (1) DE2421943A1 (he)
FR (1) FR2228477B1 (he)
GB (1) GB1473601A (he)
HK (1) HK41280A (he)
IE (1) IE42002B1 (he)
IL (1) IL44779A (he)
MY (1) MY8100128A (he)
NL (1) NL7406098A (he)
NZ (1) NZ174192A (he)
PL (1) PL97318B1 (he)
SE (1) SE7406096L (he)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
CA1054937A (en) * 1975-01-28 1979-05-22 Gursaran P. Talwar Antipregnancy vaccine
FR2319379A1 (fr) * 1975-07-29 1977-02-25 All India Inst Medical Scie Vaccin contre la gravidite et procede de sa preparation
JPS55160725A (en) * 1975-07-30 1980-12-13 Paashiyado Taruwaa Gaasaran Contraceptive vaccine and its manufacture
NZ182272A (en) * 1975-10-14 1985-03-20 Univ Ohio State Modified polypeptides for the immunological control of fertility,and pharmaceutical compositions
JPS5294416A (en) * 1976-01-24 1977-08-09 Paashiyado Taruwaa Gaasaran Vaccine for contraception and use of same
JPS5633907Y2 (he) * 1976-09-16 1981-08-11
US4096237A (en) * 1977-03-14 1978-06-20 Hoffmann-La Roche Inc. Immunoassay for β-endorphin
US4234561A (en) * 1978-02-06 1980-11-18 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4310455A (en) * 1979-04-17 1982-01-12 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
CA1239346A (en) * 1985-06-04 1988-07-19 Gursaran P. Talwar Birth control vaccine
FR2832066A1 (fr) * 2001-11-14 2003-05-16 Agronomique Inst Nat Rech Compositions vaccinales contraceptives comprenant un peptide ou un ensemble de peptides codes par tout ou partie de l'exon 1 d'un recepteur de la fsh

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA903671A (en) * 1972-06-27 J. Lewis Andrew Soluble cancer antigens coupled to foreign proteins
DE1467782A1 (de) * 1963-07-17 1968-12-12 Behringwerke Ag Verfahren zur Herstellung von kuenstlichen Antigenen
US3317400A (en) * 1964-11-23 1967-05-02 Upjohn Co Enzymatic modification of bovine growth hormone by proteolytic streptomycete cell extracts
GB1393965A (en) * 1971-05-05 1975-05-14 Ortho Pharma Corp Vaccine and method for inducing infertility in a male animal

Also Published As

Publication number Publication date
DD113919A5 (de) 1975-07-05
ATA377074A (de) 1979-09-15
CH622426A5 (en) 1981-04-15
GB1473601A (en) 1977-05-18
JPS5069221A (he) 1975-06-10
IL44779A (he) 1977-10-31
SE7406096L (sv) 1975-01-31
FR2228477B1 (he) 1977-07-01
DE2421943C2 (he) 1989-10-26
IL44779A0 (en) 1974-07-31
HK41280A (en) 1980-08-15
AU6869574A (en) 1975-11-13
CA1057742A (en) 1979-07-03
DE2421943A1 (de) 1974-11-28
IE42002L (en) 1974-11-07
MY8100128A (en) 1981-12-31
NL7406098A (he) 1974-11-11
AU524925B2 (en) 1982-10-14
NZ174192A (en) 1985-02-28
JPS623128B2 (he) 1987-01-23
FR2228477A1 (he) 1974-12-06
IE42002B1 (en) 1980-05-21
PL97318B1 (pl) 1978-02-28

Similar Documents

Publication Publication Date Title
AT356263B (de) Verfahren zur herstellung eines antigens fuer die verwendung bei der immunologischen kontrolle der fortpflanzung
AT346201B (de) Verfahren zur herstellung von schleifkoerpern
AT335995B (de) Verfahren zur herstellung von ketoisophoron
AT370714B (de) Verfahren zur herstellung von aldehyden
AT343295B (de) Verfahren zur herstellung neuer haptensteroide
AT341083B (de) Verfahren zur herstellung neuer rifamycine
AT362497B (de) Verfahren zur herstellung von tumor-antigenen
AT338232B (de) Verfahren zur herstellung von ketoisophoron
AT341118B (de) Verfahren zur herstellung neuer dotriacontapeptidamide
AT340901B (de) Verfahren zur herstellung neuer substituierter benzophenone
AT342015B (de) Verfahren zur herstellung von acetoacetamid-n-sulfofluorid
AT336634B (de) Verfahren zur herstellung von poly-n-alkyliminoalanen
AT351768B (de) Verfahren zur herstellung eines antistruktur- mittelgemisches
AT343629B (de) Verfahren zur herstellung von 2-arylpropionaldehyden
DD130933A5 (de) Verfahren zur herstellung von sulfinylazetidinonen
ATA895774A (de) Verfahren zur herstellung geblaehter riolit- glaeser
AT344666B (de) Verfahren zur herstellung eines oxychlorierungskatalysators
AT356055B (de) Verfahren zur herstellung eines schussfaden- losen bandes
AT344329B (de) Verfahren zur herstellung von antigenen
AT346275B (de) Verfahren zur herstellung von briketts
ATA652574A (de) Verfahren zur herstellung von 6-methyl-5-hepten-2-onverfahren zur herstellung von 6-methyl-5-hepten-2-on
AT340885B (de) Verfahren zur herstellung von acetoacetamid-n-sulfofluorid
AT387375B (de) Kontinuierliches verfahren zur herstellung von chlordioxid
DD129268A3 (de) Verfahren zur herstellung hochstyrolhaltiger latices
DD135911A1 (de) Verfahren zur herstellung eines tumorantigens

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee